Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea
- Conditions
- Gastric CancerGastroesophageal Junction Cancer
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1695
- Registration Number
- NCT02538562
- Locations
- 🇰🇷
Chonbuk National Uni Hospital, Jeollabuk-do, Korea, Republic of
🇰🇷Inje university Haeundae Paik Hospital, Busan, Korea, Republic of
🇰🇷Inje University Busan Paik Hospital, Busan, Korea, Republic of
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 505
- Registration Number
- NCT02536664
An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants
- Conditions
- Breast Cancer
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 580
- Registration Number
- NCT02535026
A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 60
- Registration Number
- NCT02534311
Basmisanil Positron Emission Tomography Study in Japanese Volunteers
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 6
- Registration Number
- NCT02534207
- Locations
- 🇬🇧
Hammersmith Medicines Research; Central Middlesex Hospital, London, United Kingdom
🇬🇧Imanova Limited, London, United Kingdom
A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
- Conditions
- Lymphocytic Leukemia, Chronic
- Interventions
- First Posted Date
- 2015-08-26
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 34
- Registration Number
- NCT02533401
A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 582
- Registration Number
- NCT02528747
A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants
- First Posted Date
- 2015-08-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 44
- Registration Number
- NCT02525484
A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 33
- Registration Number
- NCT02521610
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 43
- Registration Number
- NCT02515669
- Locations
- 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
🇨🇦Children'S Hospital of Eastern Ontario, Ottawa, Ontario, Canada
🇺🇸Saint Louis Children's Hospital, Saint Louis, Missouri, United States